Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction

被引:34
作者
Galve, E
Mallol, A
Catalan, R
Palet, J
Méndez, S
Nieto, E
Diaz, A
Soler-Soler, J
机构
[1] Hosp Gen Hosp Hebron, Serv Cardiol, Barcelona 08035, Spain
[2] Hosp Gen Univ Hebron, Serv Bioquim, Barcelona, Spain
关键词
heart failure; diuretics; neurohumoral activation;
D O I
10.1016/j.ejheart.2004.09.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Loop diuretics are beneficial in heart failure in the short term because they eliminate fluid retention, but in the long-term, they could adversely influence prognosis due to activation of neurohumoral mechanisms. Aims: To explore the changes induced by diuretic withdrawal in chronic nonadvanced heart failure. Methods: Diuretics were withdrawn in 26 stabilized heart failure patients with systolic dysfunction (ejection fraction [EF]< 45%). Clinical status was evaluated by physical exam, exercise capacity (corridor test) and New York Heart Association (NYHA) class. Biochemical and neurohumoral determinations were performed at baseline and at 3 months. Results: At 3 months, 17 out of 26 patients (65%) were able to tolerate diuretic interruption without a deterioration in exercise capacity or New York Heart Association functional class. Renal function parameters improved (baseline urea 46.2 +/- 10.8 to 39.2 +/- 10.1 mg/dl at 3 months, p=0.014; creatinine 1.1 +/- 0.23 to 0.98 +/- 0.2 mg/dl, p=0.013). Glucose metabolism also improved (fasting glucose 151 91 to 122 +/- 14 mg/dl, p=0.035). Heart rate and systolic blood pressure did not significantly change, while diastolic blood pressure increased (from 80 +/- 10 to 87 +/- 13 mm Hg, p=0.006). Neurohumoral determinations showed a decrease in plasma renin activity (4.19 +/- 5.96 to 2.88 +/- 4.98 ng/ml, p=0.026), with no changes in aldosterone, arginine-vasopressin, endothelin-1 and norepinephrine. In contrast, atrial natriuretic peptide significantly increased (115 +/- 87 to 168 +/- 155 pg/ml, p=0.004). Conclusion: Diuretic withdrawal in stabilized heart failure with systolic dysfunction is associated with an improvement in renal function parameters, glucose metabolism and some neurohumoral parameters, such as plasma renin activity; however, atrial natriuretic peptide levels increased. (c) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:892 / 898
页数:7
相关论文
共 50 条
  • [1] Diuretic Therapy in Elderly Heart Failure Patients With and Without Left Ventricular Systolic Dysfunction
    Dave J. W. van Kraaij
    René W. M. M. Jansen
    Frank W. J. Gribnau
    Willibrord H. L. Hoefnagels
    Drugs & Aging, 2000, 16 : 289 - 300
  • [2] The prognostic significance of renal dysfunction in patients with chronic systolic heart failure
    S. Raja Laskar
    Daniel L. Dries
    Current Cardiology Reports, 2003, 5 (3) : 205 - 210
  • [3] Clinical outcome and reversibility of systolic dysfunction in patients with dilated cardiomyopathy due to hypertension and chronic heart failure
    Sánchez, MA
    Esteban, MR
    Pineda, SO
    Ortiz, MR
    Peña, ER
    Rubio, DM
    Belsué, FV
    REVISTA ESPANOLA DE CARDIOLOGIA, 2004, 57 (09): : 834 - 841
  • [4] Cardiac and renal dysfunction in chronic heart failure: Relation to neurohumoral activation and prognosis
    Marenzi, G
    Lauri, G
    Guazzi, M
    Assanelli, E
    Grazi, M
    Famoso, G
    Agostoni, P
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2001, 321 (06) : 359 - 366
  • [5] The Prognostic Value of Diuretic Dose in Stable Chronic Heart Failure Patients
    Triggiani, Marco
    Manerba, Alessandra
    Lupi, Laura
    Suardi, Silvia
    Pizzuto, Annalisa
    Dasseni, Nicolo
    Houndjeu, Arnaud Romeo Mbadjeu
    Cesana, Bruno Mario
    Gheorghiade, Mihal
    Nodari, Savina
    CIRCULATION, 2013, 128 (22)
  • [6] Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function
    Macín, SM
    Perna, ER
    Canella, JPC
    Alvarenga, P
    Pantich, R
    Ríos, N
    Farías, EF
    Badaracco, JR
    REVISTA ESPANOLA DE CARDIOLOGIA, 2004, 57 (01): : 45 - 52
  • [7] Role of left ventricular systolic and diastolic dysfunction in clinical manifestations of chronic heart failure and in patients with prior myocardial infarction
    Kalyuzhin, VV
    Teplyakov, AT
    Solovtsov, MA
    TERAPEVTICHESKII ARKHIV, 2002, 74 (12) : 15 - 18
  • [8] Clinical Outcomes of Metabolic Surgery on Diuretic Use in Patients With Heart Failure
    Kachmar, Michael
    Corpodean, Florina
    LaChute, Courtney
    Popiv, Iryna
    Cook, Michael W.
    Danos, Denise M.
    Albaugh, Vance L.
    Moraes, Denzil L.
    Tang, W. H. Wilson
    Schauer, Philip R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 226 : 128 - 133
  • [9] Sleep apnea prevalence in chronic heart failure patients with severe left ventricle systolic dysfunction
    Hlasensky, Jiri
    Zikmund-Galkova, Lujza
    Ludka, Ondrej
    BIOMEDICAL PAPERS-OLOMOUC, 2017, 161 : S12 - S14
  • [10] Global longitudinal strain as a potential prognostic marker in patients with chronic heart failure and systolic dysfunction
    Rangel, Ines
    Goncalves, Alexandra
    de Sousa, Carla
    Almeida, Pedro Bernardo
    Rodrigues, Joao
    Macedo, Filipe
    Cardoso, Jose Silva
    Maciel, Ma Julia
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2014, 33 (7-8) : 403 - 409